Editorial Commentary : Arthroscopic Treatment of Femoroacetabular Impingement Yields Long‐Term Patient Satisfaction
Arthroscopy · 2025-06 · 41 (6) · 1786-1787
DOI: 10.1016/j.arthro.2024.09.016 ↗Kurz gefasst
Editorial in der Zeitschrift Arthroscopy, online erschienen am 18.09.2024. Verfasst von Derek H Ochiai. Hauptthemen laut MEDLINE: Femoracetabular Impingement, Arthroscopy, Patient Satisfaction. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 9 Literaturangaben.
Abstract (Originalsprache)
Long‐term outcomes for arthroscopic surgery to treat hip femoroacetabular impingement syndrome show acceptable patient‐reported outcomes and durability (even on the basis of the early days of hip arthroscopy without capsular closure or labral reconstruction). Today, with modern hip arthroscopy and femoroacetabular impingement syndrome treatment including capsular closure, labral tear treatment, and refined indications, durability in terms of avoidance of conversion to total hip replacement is also expected. The advances in hip arthroscopy over the past 20 years have been breathtaking. Now, as novel arthroscopic innovations continue to develop, care must be taken to ensure that new procedures are actually improving an already well‐developed treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Zitieren
APA
Ochiai, D. H. (2025). Editorial Commentary : Arthroscopic Treatment of Femoroacetabular Impingement Yields Long‐Term Patient Satisfaction. Arthroscopy, 41(6), 1786-1787. https://doi.org/10.1016/j.arthro.2024.09.016
Vancouver
Ochiai DH. Editorial Commentary : Arthroscopic Treatment of Femoroacetabular Impingement Yields Long‐Term Patient Satisfaction. Arthroscopy. 2025;41(6):1786-1787. doi:10.1016/j.arthro.2024.09.016
BibTeX
@article{Ochiai2025,
author = {Ochiai, Derek H},
title = {Editorial Commentary : Arthroscopic Treatment of Femoroacetabular Impingement Yields Long‐Term Patient Satisfaction},
journal = {Arthroscopy},
year = {2025},
volume = {41},
number = {6},
pages = {1786--1787},
doi = {10.1016/j.arthro.2024.09.016}
}
EUVIMED